Gelesis Holdings, Inc. (GLS) |
|
0.18 0.01 (5.88%)
|
03-27 16:00 |
|
Open: |
0.1785 |
Pre. Close: |
0.17 |
|
High:
|
0.18 |
Low:
|
0.1502 |
|
Volume:
|
723,808 |
Market Cap:
|
13(M) |
|
|
|
Technical analysis |
as of: 2023-03-27 4:19:42 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 0.28  One year: 0.38 |
| Support: |
Support1: 0.1 Support2: 0.09 |
| Resistance: |
Resistance1: 0.24 Resistance2: 0.32 |
| Pivot: |
0.19 |
| Moving Average: |
MA(5): 0.16 MA(20): 0.21
MA(100): 0.3 MA(250): 1.58 |
| MACD: |
MACD(12,26): -0.1  Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 34.6 %D(3): 29.6 |
| RSI: |
RSI(14): 42.6 |
| 52-week: |
High: 5.94 Low: 0.1 |
| Average Vol(K): |
3-Month: 376 (K) 10-Days: 1,219 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ GLS ] has closed above bottom band by 38.8%. Bollinger Bands are 25.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.17 - 0.17 |
0.17 - 0.17 |
|
Low:
|
0.14 - 0.14 |
0.14 - 0.14 |
|
Close:
|
0.17 - 0.17 |
0.17 - 0.17 |
|
Company Description |
|
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts. |
Headline News |
Fri, 24 Mar 2023
Markets Today: Stock Indexes Slump on Banking Sector Woes - Barchart
Fri, 24 Mar 2023
North American Morning Briefing : Stock Futures -2- - Marketscreener.com
Wed, 22 Mar 2023
Why GameStop Shares Are Trading Higher By Around 44%; Here ... - Investing.com UK
Tue, 21 Mar 2023
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are ... - Investing.com UK
Tue, 21 Mar 2023
Where Will Gelesis Holdings Inc (GLS) Stock Go Next After It Has Fallen 31.82% in a Week? - InvestorsObserver
Tue, 21 Mar 2023
Real-Time Update: Gelesis Holdings Inc. (GLS) Stock Navigates the ... - The News Heater
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
73 (M) |
| Shares Float |
20 (M) |
|
% Held by Insiders
|
52.2 (%) |
|
% Held by Institutions
|
32.8 (%) |
|
Shares Short
|
513 (K) |
|
Shares Short P.Month
|
712 (K) |
Stock Financials |
|
EPS
|
-1.34 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-0.06 |
|
Profit Margin (%)
|
-198.5 |
|
Operating Margin (%)
|
-443.7 |
|
Return on Assets (ttm)
|
-51.8 |
|
Return on Equity (ttm)
|
-552.4 |
|
Qtrly Rev. Growth
|
120.6 |
|
Gross Profit (p.s.)
|
0.01 |
|
Sales Per Share
|
0.35 |
|
EBITDA (p.s.)
|
-1.51 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-90 (M) |
|
Levered Free Cash Flow
|
-82 (M) |
Stock Valuations |
|
PE Ratio
|
-0.14 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
-3.59 |
|
Price to Sales
|
0.5 |
|
Price to Cash Flow
|
-0.15 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
